Recent Development on Anti-Obesity Compounds and their Mechanisms of Action: A Review

Yixing Qiu1,2, Huanghe Yu1, Rong Zeng1

  • 1TCM and Ethnomedicine Innovation & Development International Laboratory, Innovative Drug Research Institute, School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.

Current Medicinal Chemistry
|February 16, 2019
PubMed

Insights

Researchers are exploring novel small molecules and natural products for safe and effective obesity treatments. This review details compounds targeting major anti-obesity pathways, offering a comprehensive overview for future drug development.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Molecular Biology

Background:

  • Obesity is a major health threat linked to diabetes, hypertension, and heart disease, increasing morbidity and mortality.
  • Current anti-obesity drugs have limitations due to side effects, driving the search for safer alternatives.
  • Numerous small molecules and natural products with anti-obesity potential have been identified, with partially revealed mechanisms.

Purpose of the Study:

  • To provide a comprehensive and updated review of compounds with anti-obesity effects.
  • To classify these compounds based on their molecular mechanisms of action.
  • To highlight progress in identifying and understanding novel anti-obesity agents.

Main Methods:

  • Literature review of scientific publications.
  • Identification and categorization of small molecules and natural products with anti-obesity properties.
  • Analysis of molecular mechanisms regulating key anti-obesity pathways.

Main Results:

  • A growing number of compounds, including novel small molecules and natural products, demonstrate anti-obesity effects.
  • The molecular mechanisms of action for many compounds have been partially elucidated.
  • Compounds target various major anti-obesity pathways.

Conclusions:

  • Significant progress has been made in identifying and understanding compounds for obesity management.
  • Further research into these compounds and their mechanisms can lead to safer and more effective anti-obesity therapies.
  • This review serves as a valuable resource for researchers in the field of obesity pharmacotherapy.

Related Concept Videos

Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
2.8K
Local Anesthetics: Mechanism of Action01:23

Local Anesthetics: Mechanism of Action

Local anesthetics (LAs) block sensory and motor impulses by inhibiting the sodium channels on the nerve cell membranes. This induces temporary loss of sensation, relieving pain in a specific body area.
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
3.3K
Radical Anti-Markovnikov Addition to Alkenes: Mechanism01:17

Radical Anti-Markovnikov Addition to Alkenes: Mechanism

The reaction of hydrogen bromide with alkenes in the presence of hydroperoxides or peroxides proceeds via anti-Markovnikov addition. The radical chain reaction comprises initiation, propagation, and termination steps.
The mechanism starts with chain initiation, which involves two steps. In the first chain initiation step, a weak peroxide bond is homolytically cleaved upon mild heating to form two alkoxy radicals. In the second initiation step, a hydrogen atom is abstracted by the alkoxy...
4.7K
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.6K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.9K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.3K